LRRK2 c.5248G>C ;(p.V1750L)

Variant ID: 12-40715914-G-C

NM_198578.3(LRRK2):c.5248G>C;(p.V1750L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Integrative analysis of multi-omics data reveals the heterogeneity and signatures of immune therapy for small cell lung cancer.

Clinical And Translational Medicine
Chen, Yabin Y; Fang, Zhaoyuan Z; Tang, Ying Y; Jin, Yujuan Y; Guo, Chenchen C; Hu, Liang L; Xu, Yang Y; Ma, Xidong X; Gao, Jie J; Xie, Mei M; Zang, Xuelei X; Liu, Sanhong S; Chen, Haiquan H; Thomas, Roman K RK; Xue, Xinying X; Ji, Hongbin H; Chen, Luonan L
Publication Date: 2021-12

Variant appearance in text: LRRK2: V1750L
PubMed Link: 34923768
Variant Present in the following documents:
  • CTM2-11-e620-s006.xlsx, sheet 2
View BVdb publication page



Beyond TNBC: Repositioning of Clofazimine Against a Broad Range of Wnt-Dependent Cancers.

Frontiers In Oncology
Xu, Jiabin J; Koval, Alexey A; Katanaev, Vladimir L VL
Publication Date: 2020

Variant appearance in text: LRRK2: V1750L
PubMed Link: 33363033
Variant Present in the following documents:
  • Main text
View BVdb publication page